Histamine dihydrochloride with interleukin-2 for maintenance treatment of acute myeloid leukaemia [ID1627]
In development
Reference number: GID-TA10575
Expected publication date: TBC
NICE must unfortunately postpone the first committee discussion for this topic, scheduled for 4 February 2026. We will instead reschedule the first committee discussion to 9 April 2026.